GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CRISPR Therapeutics AG (STU:1CG) » Definitions » Other Current Payables

CRISPR Therapeutics AG (STU:1CG) Other Current Payables : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is CRISPR Therapeutics AG Other Current Payables?

CRISPR Therapeutics AG's Other Current Payables for the quarter that ended in Mar. 2024 was €0.0 Mil.

CRISPR Therapeutics AG's quarterly Other Current Payables declined from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€-0.0 Mil) but then increased from Dec. 2023 (€-0.0 Mil) to Mar. 2024 (€0.0 Mil).

CRISPR Therapeutics AG's annual Other Current Payables stayed the same from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then declined from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€-0.0 Mil).


CRISPR Therapeutics AG Other Current Payables Historical Data

The historical data trend for CRISPR Therapeutics AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISPR Therapeutics AG Other Current Payables Chart

CRISPR Therapeutics AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CRISPR Therapeutics AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CRISPR Therapeutics AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


CRISPR Therapeutics AG Other Current Payables Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


CRISPR Therapeutics AG (STU:1CG) Business Description

Traded in Other Exchanges
Address
Baarerstrasse 14, Zug, CHE, CH-6300
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

CRISPR Therapeutics AG (STU:1CG) Headlines

No Headlines